India’s smaller cities and hinterland remain a neglected lot even as five-star specialty hospitals flourish in the metros. To have its healthcare parameters on track, India needs an urgent flow of investments in tertiary-care hospitals in tier-II and tier-III cities. But building and managing tertiary-care hospitals isn’t easy. Examples like Ujala Cygnus can show the way forward.
Related Posts
us shark tank: Selling cut-price generics, Mark Cuban is shaking up US pharma. Can Indian drug makers benefit?
Getty Images Mark Cuban. Synopsis Most of the large Indian pharma companies earn a big chunk of their revenue by supplying drugs to the US market. Shark Tank attraction Cuban’s online pharmacy launched last year, which sources medicines directly from manufacturers, holds the promise of catalysing the US businesses of Indian generic drug makers. US-based […]
An army of 12,000 medical reps: How Rajeev Juneja flexed Mankind to the pharma top order
Synopsis While Ramesh Juneja has led Mankind Pharma for three decades, his brother Rajeev kept in tow and took charge of key operations. Suave and yet rustic, the younger Juneja has a unique style to push the 12,000-strong team of medical representatives in a fiercely competitive market and can sense the pulse of his people […]
cipla: Leap of faith: how Cipla veteran Nikhil Chopra got JB Pharma out of the woods, on to a growth path
Nikhil Chopra, CEO, JB Chemicals and Pharmaceuticals Ltd. Image credit: Special Arrangement Synopsis When PE firm KKR took control of JB Pharma in 2020, it was struggling for growth. Competitors had cornered the four legacy brands on which the company relied. Then, Nikhil Chopra, a seasoned hand from Cipla, took over. JB Pharma’s subsequent turnaround […]